DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 171 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q2 2020. The put-call ratio across all filers is 1.02 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,070 | +22.4% | 162,699 | +35.5% | 0.18% | +4.7% |
| Q2 2023 | $1,691 | +7.1% | 120,095 | +17.5% | 0.17% | +8.3% |
| Q1 2023 | $1,579 | +41.1% | 102,231 | +49.7% | 0.16% | +12.2% |
| Q4 2022 | $1,119 | -99.6% | 68,289 | +379.3% | 0.14% | +297.1% |
| Q3 2022 | $264,000 | -19.5% | 14,247 | -42.8% | 0.04% | -28.6% |
| Q2 2022 | $328,000 | +89.6% | 24,923 | +33.2% | 0.05% | +113.0% |
| Q1 2022 | $173,000 | +15.3% | 18,713 | +21.6% | 0.02% | +21.1% |
| Q4 2021 | $150,000 | -92.7% | 15,388 | -74.6% | 0.02% | -91.0% |
| Q3 2021 | $2,057,000 | +637.3% | 60,550 | +1138.2% | 0.21% | +356.5% |
| Q4 2020 | $279,000 | -29.0% | 4,890 | -48.8% | 0.05% | -53.5% |
| Q1 2020 | $393,000 | – | 9,548 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 1,209,571 | $69,030,000 | 15.95% |
| SV Health Investors, LLC | 449,951 | $25,679,000 | 12.37% |
| Sunesis Advisors, LLC | 96,299 | $5,496,000 | 4.45% |
| Redmile Group, LLC | 4,437,968 | $253,275,000 | 3.07% |
| Consonance Capital Management LP | 484,671 | $27,660,000 | 2.58% |
| SECTORAL ASSET MANAGEMENT INC | 488,842 | $27,898,000 | 1.97% |
| Opaleye Management Inc. | 222,000 | $12,670,000 | 1.66% |
| Eversept Partners, LP | 246,240 | $14,052,917 | 1.65% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 38,620 | $2,204,000 | 1.28% |
| Avoro Capital Advisors LLC | 1,300,000 | $74,191,000 | 1.28% |